ORTEXORTEX News
Tracking CCK? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CC
Earnings PreviewCCK

Crown Holdings Bulls Hold the Line Into Monday's Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 20 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Crown Holdings arrives at its Q3 earnings release on October 20 with the bullish tilt that was the story four days ago largely intact, though options positioning has pulled back from its record extreme.

The put/call ratio, which collapsed to a 52-week low of 0.13 on October 15, has since normalized to 0.22. That remains more than one standard deviation below the 20-day average of 0.28, still tilted toward calls rather than protective puts, but no longer the historic outlier flagged in Thursday's preview. The stock itself edged up another 1.1% on Monday to $114.89, adding to a 5.9% weekly gain. Packaging peers moved in the same direction: Ball added 8.1% on the week and Silgan rose 6.7%, confirming that sector tailwinds rather than Crown-specific flow are doing much of the lifting.

Short interest has continued to unwind in the run-up, reinforcing the constructive setup. Bears have trimmed positions by roughly 9% over the past week and 17% over the past month, leaving short interest at just 2.1% of the free float. The borrow market remains effectively open, with availability at more than 3,600% of short interest and a cost to borrow of 0.22%, down sharply from above 0.60% in early October. There is no squeeze pressure and no sign of fresh short conviction building into the print.

The Street's debate is genuine. Bulls point to the Q2 beat, where adjusted operating EPS came in at $2.49 against a $2.12 estimate, and to raised full-year guidance of $8.30 to $8.50. Sustained beverage-can demand, substrate conversion projects in Europe, and a planned $200 million in share repurchases in the second half underpin the optimistic case. Bears counter with FX headwinds, aluminum and natural gas cost exposure, and volume pressure in European and Southeast Asian markets. JPMorgan upgraded to Overweight in mid-September with a $121 target, while Wells Fargo trimmed its target by $1 to $126 on the morning of the print while holding its Equal-Weight rating. UBS cut its target to $116 in early October from $123. The consensus mean target of $134.86 implies roughly 17% upside from current levels, suggesting the Street still sees room to run even after this year's gains.

The print will test whether Crown's Q2 momentum has carried into Q3, and whether management's ability to offset currency and raw material drag is durable enough to justify the multiple expansion the stock has already taken.

Stocks in this article

See the live data behind this article on ORTEX.

Open CCK on ORTEX →

How this article was generated

Generated
20 Oct 2026, 04:03
Data as of
20 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.